Daily Intelligence Brief
Depo-Provera Commands 62 New Federal Filings as Social Media and Chemical Dockets Hold Pace
LexGenius tracked 62 new federal filings yesterday, with the Depo-Provera Products Liability Litigation (MDL 3140) commanding the highest volume at 24 new suits. Seeger Weiss led the charge with 10 filings, supported by Hochman Law Firm PLLC and Weitz & Luxenberg PC, as plaintiffs continue to allege the contraceptive injection causes significant neurological injuries. The Social Media Adolescent Addiction Personal Injury Products Liability Litigation (MDL 3047) saw 8 new filings driven primarily by the Law Offices of Charles H Johnson PA alongside Motley Rice. The Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL 3060) and the Aqueous Film-Forming Foams Products Liability Litigation (MDL 2873) each added 6 new cases, with Singleton Schreiber LLP anchoring the hair relaxer filings and Krentsel & Guzman LLP single-handedly filing all six AFFF actions.Camp Lejeune Settlement Delays Trigger Congressional Scrutiny as Payout Backlog Persists
The Camp Lejeune Water Litigation faces mounting pressure as settlement payments to eligible claimants remain stalled months after congressional appropriations were supposed to unlock the $6 billion compensation fund, according to a Spectrum News report from April 15. The delay affects thousands of veterans and family members who developed cancers and other illnesses from contaminated drinking water at the North Carolina base between 1953 and 1987, with administrative bottlenecks in the Navy's adjudication process cited as the primary holdup. The stagnation contrasts sharply with the litigation's early momentum — the Camp Lejeune Justice Act of 2022 opened a two-year window for claims that generated over 100,000 administrative filings — and raises the prospect of renewed legislative intervention if the Navy cannot demonstrate measurable progress before the August 2026 deadline. Plaintiff firms with significant Camp Lejeune inventories, including Bell Legal Group, face client management challenges as expectations set by early settlement announcements collide with payment realities.GLP-1 Litigation Broadens on Two Fronts as Agricultural Chemical and Device Dockets Add Steady Volume
The Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Products Liability (Gastroparesis) Litigation (MDL 3094) added new complaints spearheaded by Motley Rice and Wagstaff & Cartmell LLP, while the parallel Glucagon-like Peptide-1 Receptor Agonists Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation (MDL 3163) registered a new suit filed by Searcy Denney Scarola Barnhart & Shipley PA — evidence that GLP-1 injury theories continue to diversify beyond the gastroparesis flagship. Elsewhere, Levin Papantonio filed three new suits in the Polypropylene Hernia Mesh Products Liability Litigation, and agricultural chemical exposure dockets saw continued activity as Cory Watson PC and Meshbesher & Spence added to the Roundup Products Liability Litigation while Pulaski Kherkher PLLC filed a new action in the Paraquat Products Liability Litigation. Rounding out the day, Cutter Law PC introduced a new claim in the Uber Technologies, Inc., Passenger Sexual Assault Litigation (MDL 3084), adding to the ongoing legal pressure on rideshare platform safety protocols.Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.
